Delivery Order SPE2DB22D3016-SPE2DB24FAHW1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $7,446.94 firm fixed price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a completion date of January 5, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $17,729.87 firm fixed price delivery order is for the supply of STELARA 90 MG/ML syringes. The contract does not have a set-aside designation and the period of performance ends on January 4, 2024. Amerisourcebergen Drug Corp has a history of providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $106,156.58 delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and related distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $19,712.27 firm fixed price delivery order is for the supply of STELARA 90 MG/ML syringes. This award is associated with an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $111,993.15 firm fixed price delivery order was for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products. The contract has no set-aside designation and the period of performance is through August 1, 2022. Amerisourcebergen Drug Corp, through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $111,681.80 firm fixed price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has an existing indefinite delivery contract with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $22,908.06 firm fixed price delivery order is for the supply of STELARA 90 MG/ML SYRINGE medication. The contract does not have a set-aside designation and performance will take place at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp has an established...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $16,607.52 fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,284.73 firm-fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty pharmaceutical product. The contract has a period of performance through July 2024 and is not set aside for any specific business category. Amerisourcebergen, a major pharmaceutical distributor, has been awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,080.84 firm fixed price delivery order is for the provision of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAHW1Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $8,151.02 firm fixed price delivery order is for the supply of STELARA 90 MG/ML syringes. The contract has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has received numerous federal contract awards from DLA to provide pharmaceutical products and medical supplies in support of military treatment programs and facilities. This award does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 1/9/24 |